Lamivudine
Brands containing Lamivudine, food notes, and the most important drug interactions.
BRANDS
5- EPIVIR 150 MG 60 TABLETbarcode: 8699522092666
- EPIVIR 240 ML ORAL SOLUSYONbarcode: 8699522592654
- MEDOVIR 100 MG FILM KAPLI TABLET (28 TABLET)barcode: 8699536093048
- MIVUX 100 MG 28 FILM TABLETbarcode: 8699540099005
- ZEFFIX 100 MG 28 TABLETbarcode: 8699522096008
FOOD NOTES
1Take with or without food. Food delays drug absorption, but not to a clinically significant extent.
Template translation
MOST IMPORTANT INTERACTIONS
first 10 of 50- Alendronic acidMAJOR
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Alendronic acid is combined with Lamivudine.
Expert view
- Amphotericin BMAJOR
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Lamivudine.
Expert view
- BaclofenMAJOR
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Lamivudine.
Expert view
- BetamethasoneMAJOR
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Betamethasone is combined with Lamivudine.
Expert view
- CarbimazoleMAJOR
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Carbimazole is combined with Lamivudine.
Expert view
- CerivastatinMAJOR
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cerivastatin is combined with Lamivudine.
Expert view
- ChloroquineMAJOR
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Lamivudine.
Expert view
- CiprofloxacinMAJOR
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Lamivudine.
Expert view
- CladribineMAJOR
The serum concentration of the active metabolites of Cladribine can be decreased when Cladribine is used in combination with Lamivudine.
Expert view
- ClofibrateMAJOR
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Lamivudine.
Expert view